Safety, activity, and molecular heterogeneity following neoadjuvant non-pegylated liposomal doxorubicin, paclitaxel, trastuzumab, and pertuzumab in HER2-positive breast cancer (Opti-HER HEART): an open-label, single-group, multicenter, phase 2 trial. (Record no. 29233156)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02326 a2200625 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250518015335.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201907s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1741-7015 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1186/s12916-018-1233-1 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Gavilá, Joaquín |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20190705 |
| 245 00 - TITLE STATEMENT | |
| Title | Safety, activity, and molecular heterogeneity following neoadjuvant non-pegylated liposomal doxorubicin, paclitaxel, trastuzumab, and pertuzumab in HER2-positive breast cancer (Opti-HER HEART): an open-label, single-group, multicenter, phase 2 trial. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | BMC medicine |
| Date of publication, distribution, etc. | 01 2019 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 8 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antibodies, Monoclonal, Humanized |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Breast Neoplasms |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cardiotoxicity |
| General subdivision | epidemiology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Chemotherapy, Adjuvant |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Doxorubicin |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Neoadjuvant Therapy |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Paclitaxel |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Polyethylene Glycols |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Receptor, ErbB-2 |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Trastuzumab |
| General subdivision | administration & dosage |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Oliveira, Mafalda |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Pascual, Tomás |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Perez-Garcia, Jose |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gonzàlez, Xavier |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Canes, Jordi |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Paré, Laia |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Calvo, Isabel |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ciruelos, Eva |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Muñoz, Montserrat |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Virizuela, Juan A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ruiz, Isabel |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Andrés, Raquel |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Perelló, Antonia |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Martínez, Jerónimo |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Morales, Serafín |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Marín-Aguilera, Mercedes |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Martínez, Débora |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Quero, Juan C |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Llombart-Cussac, Antonio |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Prat, Aleix |
| 773 0# - HOST ITEM ENTRY | |
| Title | BMC medicine |
| Related parts | vol. 17 |
| -- | no. 1 |
| -- | p. 8 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1186/s12916-018-1233-1">https://doi.org/10.1186/s12916-018-1233-1</a> |
| Public note | Available from publisher's website |
No items available.